MedTrace Logo

Telmisartan Fixed Dose Combination vs Amlodipine in Hypertensive Patients With Type 2 Diabetes Mellitus

NCT00877929 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 706

Last updated 2014-03-12

Study results available
· View outcomes & findings →

Summary

To demonstrate that the fixed dose combination of telmisartan and amlodipine is more effective in lowering blood pressure.

Conditions

Interventions

DRUG

Telmisartan 80

Telmisartan 80 mg

DRUG

Amlodipine 10

Amlodipine 5 for two weeks, then forced titration to Amlodipine 10

DRUG

Amlodipine 10

Amlodipine 5 for two weeks, then forced titration to Amlodipine 10

Sponsors & Collaborators

Principal Investigators

  • Boehringer Ingelheim · Boehringer Ingelheim

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2010-05-31

Countries

  • United States
  • Argentina
  • Mexico
  • Netherlands
  • Slovakia
  • South Africa
  • South Korea
  • Spain
  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00877929 on ClinicalTrials.gov